596 related articles for article (PubMed ID: 27626365)
21. Patient-reported outcome measures after treatment for prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata).
Nguyen-Nielsen M; Møller H; Tjønneland A; Borre M
Cancer Epidemiol; 2020 Feb; 64():101623. PubMed ID: 31760356
[TBL] [Abstract][Full Text] [Related]
22. Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy.
Fulmer BR; Bissonette EA; Petroni GR; Theodorescu D
Cancer; 2001 Jun; 91(11):2046-55. PubMed ID: 11391584
[TBL] [Abstract][Full Text] [Related]
23. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer.
Namiki S; Tochigi T; Kuwahara M; Ioritani N; Terai A; Numata I; Satoh M; Saito S; Koinuma N; Arai Y
Int J Urol; 2004 Aug; 11(8):619-27. PubMed ID: 15285752
[TBL] [Abstract][Full Text] [Related]
24. Effect of treatment on quality of life among men with clinically localized prostate cancer.
Schapira MM; Lawrence WF; Katz DA; McAuliffe TL; Nattinger AB
Med Care; 2001 Mar; 39(3):243-53. PubMed ID: 11242319
[TBL] [Abstract][Full Text] [Related]
25. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
26. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
Bradley EB; Bissonette EA; Theodorescu D
BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
[TBL] [Abstract][Full Text] [Related]
27. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
[TBL] [Abstract][Full Text] [Related]
28. Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
Lane JA; Donovan JL; Young GJ; Davis M; Walsh EI; Avery KNL; Blazeby JM; Mason MD; Martin RM; Peters TJ; Turner EL; Wade J; Bollina P; Catto JWF; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Oxley J; Paul A; Paez E; Rosario DJ; Rowe E; Staffurth J; Neal DE; Hamdy FC; Metcalfe C;
BJU Int; 2022 Sep; 130(3):370-380. PubMed ID: 35373443
[TBL] [Abstract][Full Text] [Related]
29. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
[TBL] [Abstract][Full Text] [Related]
30. Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.
Guedea F; Ferrer M; Pera J; Aguiló F; Boladeras A; Suárez JF; Cunillera O; Ferrer F; Pardo Y; Martínez E; Ventura M
Clin Transl Oncol; 2009 Jul; 11(7):470-8. PubMed ID: 19574206
[TBL] [Abstract][Full Text] [Related]
31. Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial.
Sanghera S; Mohiuddin S; Coast J; Garfield K; Noble S; Metcalfe C; Lane JA; Turner EL; Neal D; Hamdy FC; Martin RM; Donovan JL;
BMC Cancer; 2020 Oct; 20(1):971. PubMed ID: 33028256
[TBL] [Abstract][Full Text] [Related]
32. Quality of life in men undergoing active surveillance for localized prostate cancer.
Bergman J; Litwin MS
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):242-9. PubMed ID: 23271780
[TBL] [Abstract][Full Text] [Related]
33. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
[TBL] [Abstract][Full Text] [Related]
34. Bother problems in prostate cancer patients after curative treatment.
Stensvold A; Dahl AA; Brennhovd B; Småstuen MC; Fosså SD; Lilleby W; Steinsvik A; Axcrona K; Smeland S
Urol Oncol; 2013 Oct; 31(7):1067-78. PubMed ID: 22341412
[TBL] [Abstract][Full Text] [Related]
35. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study.
Houédé N; Rébillard X; Bouvet S; Kabani S; Fabbro-Peray P; Trétarre B; Ménégaux F
BMC Cancer; 2020 Aug; 20(1):757. PubMed ID: 32787797
[TBL] [Abstract][Full Text] [Related]
36. Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality Radiotherapy.
Tward JD; O'Neil B; Boucher K; Kokeny K; Lowrance WT; Lloyd S; Cannon D; Stephenson RA; Agarwal N; Farr T; Petragallo R; Sherar NZ; Kunz I; Hofer A; Courdy S; Shrieve DC; Dechet C
Clin Genitourin Cancer; 2020 Aug; 18(4):274-283.e5. PubMed ID: 32335059
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
[TBL] [Abstract][Full Text] [Related]
38. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.
Stanford JL; Feng Z; Hamilton AS; Gilliland FD; Stephenson RA; Eley JW; Albertsen PC; Harlan LC; Potosky AL
JAMA; 2000 Jan; 283(3):354-60. PubMed ID: 10647798
[TBL] [Abstract][Full Text] [Related]
39. Long-term functional outcomes after treatment for localized prostate cancer.
Resnick MJ; Koyama T; Fan KH; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Potosky AL; Stanford JL; Stroup AM; Van Horn RL; Penson DF
N Engl J Med; 2013 Jan; 368(5):436-45. PubMed ID: 23363497
[TBL] [Abstract][Full Text] [Related]
40. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
Rosenberg JE; Jung JH; Edgerton Z; Lee H; Lee S; Bakker CJ; Dahm P
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013641. PubMed ID: 32813279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]